Infections caused by Aspergillus species are an emerging cause of morbidity and mortality
in a variety of immunocompromised patients, despite profound environmental protection and …

Aspergillus infections are a threat to in patients with hematological malignancies. Known risk
factors are profound and long lasting neutropenia, uncontrolled graft versus host disease …

Diseases caused by Aspergillus species are numerous, ranging from allergic
manifestations, to pulmonary saprophytic or locally destructive disease, to the almost …

Despite significant advances in the management of immunosuppressed patients, invasive
aspergillosis remains an important life-threatening complication. In the past two decades …

Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is
because of the higher number of patients with malignancies treated with intensive …

Invasive aspergillosis (IA) is a severe fungal infection caused by Aspergillus species,
particularly Aspergillus fumigatus, although new species, sometimes resistant to antifungals …

Aspergillosis comprises a variety of manifestations of infection. These guidelines are
directed to 3 principal entities: invasive aspergillosis, involving several organ systems …

The past decade has witnessed significant progress in the management of invasive
aspergillosis. Potent, relatively non-toxic antifungal drugs, data on early chest CT scanning …

These guidelines, which are based on recommendations established by several drug
agencies, analyze various aspects of the clinical management of different types of invasive …

Aspergillus spp. remain the most common causes of invasive mould infections among
patients with hematologic malignancies and recipients of solid-organ and hematopoietic …